Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies

Simone Ferrero, Umberto Leone Roberti Maggiore, Carolina Scala, Martina Di Luca, Pier Luigi Venturini, Valentino Remorgida

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: To evaluate the changes in the volume of rectovaginal endometriotic nodules infiltrating the rectum during 12-month treatment with hormonal therapies. Materials and methods: This prospective, non-randomized, self-controlled clinical trial included patients with rectovaginal endometriotic nodules infiltrating at least the muscularis propria of the rectum, who received one of the following therapies: norethisterone acetate, triptorelin and tibolone, norethisterone acetate and letrozole, desogestrel, sequential oral contraceptive pill. The volume of the nodules was determined by virtual organ computer-aided analysis (VOCAL, GE Healthcare, USA) at baseline and after 6 and 12 months of treatment. Results: Eighty-three women (90.2 %) completed the 12-month treatment. When compared with baseline values, the volume of the nodules decreased at 6-month (p <0.001) and 12-month treatment (p <0.001). After 12-month treatment, the volume of the nodules decreased in all study groups. The volume of the nodules decreased during therapy in 68 women (73.9 %) and increased in 11 women (12.0 %). Conclusion: 12-month administration of hormonal therapies reduces the volume of rectovaginal endometriotic nodules infiltrating the rectum in the majority of cases.

Original languageEnglish
Pages (from-to)447-453
Number of pages7
JournalArchives of Gynecology and Obstetrics
Volume287
Issue number3
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Rectum
tibolone
Therapeutics
letrozole
Contraceptives, Oral, Sequential
Triptorelin Pamoate
Desogestrel
Delivery of Health Care

Keywords

  • Desogestrel
  • Letrozole
  • Medical therapy
  • Norethisterone acetate
  • Rectal endometriosis
  • Rectovaginal endometriosis
  • Virtual organ computer-aided analysis

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies. / Ferrero, Simone; Leone Roberti Maggiore, Umberto; Scala, Carolina; Di Luca, Martina; Venturini, Pier Luigi; Remorgida, Valentino.

In: Archives of Gynecology and Obstetrics, Vol. 287, No. 3, 03.2013, p. 447-453.

Research output: Contribution to journalArticle

Ferrero, Simone ; Leone Roberti Maggiore, Umberto ; Scala, Carolina ; Di Luca, Martina ; Venturini, Pier Luigi ; Remorgida, Valentino. / Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies. In: Archives of Gynecology and Obstetrics. 2013 ; Vol. 287, No. 3. pp. 447-453.
@article{9d26757cb5894de582ae60fe324e0ac3,
title = "Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies",
abstract = "Purpose: To evaluate the changes in the volume of rectovaginal endometriotic nodules infiltrating the rectum during 12-month treatment with hormonal therapies. Materials and methods: This prospective, non-randomized, self-controlled clinical trial included patients with rectovaginal endometriotic nodules infiltrating at least the muscularis propria of the rectum, who received one of the following therapies: norethisterone acetate, triptorelin and tibolone, norethisterone acetate and letrozole, desogestrel, sequential oral contraceptive pill. The volume of the nodules was determined by virtual organ computer-aided analysis (VOCAL, GE Healthcare, USA) at baseline and after 6 and 12 months of treatment. Results: Eighty-three women (90.2 {\%}) completed the 12-month treatment. When compared with baseline values, the volume of the nodules decreased at 6-month (p <0.001) and 12-month treatment (p <0.001). After 12-month treatment, the volume of the nodules decreased in all study groups. The volume of the nodules decreased during therapy in 68 women (73.9 {\%}) and increased in 11 women (12.0 {\%}). Conclusion: 12-month administration of hormonal therapies reduces the volume of rectovaginal endometriotic nodules infiltrating the rectum in the majority of cases.",
keywords = "Desogestrel, Letrozole, Medical therapy, Norethisterone acetate, Rectal endometriosis, Rectovaginal endometriosis, Virtual organ computer-aided analysis",
author = "Simone Ferrero and {Leone Roberti Maggiore}, Umberto and Carolina Scala and {Di Luca}, Martina and Venturini, {Pier Luigi} and Valentino Remorgida",
year = "2013",
month = "3",
doi = "10.1007/s00404-012-2581-2",
language = "English",
volume = "287",
pages = "447--453",
journal = "Archives of Gynecology",
issn = "0170-9925",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies

AU - Ferrero, Simone

AU - Leone Roberti Maggiore, Umberto

AU - Scala, Carolina

AU - Di Luca, Martina

AU - Venturini, Pier Luigi

AU - Remorgida, Valentino

PY - 2013/3

Y1 - 2013/3

N2 - Purpose: To evaluate the changes in the volume of rectovaginal endometriotic nodules infiltrating the rectum during 12-month treatment with hormonal therapies. Materials and methods: This prospective, non-randomized, self-controlled clinical trial included patients with rectovaginal endometriotic nodules infiltrating at least the muscularis propria of the rectum, who received one of the following therapies: norethisterone acetate, triptorelin and tibolone, norethisterone acetate and letrozole, desogestrel, sequential oral contraceptive pill. The volume of the nodules was determined by virtual organ computer-aided analysis (VOCAL, GE Healthcare, USA) at baseline and after 6 and 12 months of treatment. Results: Eighty-three women (90.2 %) completed the 12-month treatment. When compared with baseline values, the volume of the nodules decreased at 6-month (p <0.001) and 12-month treatment (p <0.001). After 12-month treatment, the volume of the nodules decreased in all study groups. The volume of the nodules decreased during therapy in 68 women (73.9 %) and increased in 11 women (12.0 %). Conclusion: 12-month administration of hormonal therapies reduces the volume of rectovaginal endometriotic nodules infiltrating the rectum in the majority of cases.

AB - Purpose: To evaluate the changes in the volume of rectovaginal endometriotic nodules infiltrating the rectum during 12-month treatment with hormonal therapies. Materials and methods: This prospective, non-randomized, self-controlled clinical trial included patients with rectovaginal endometriotic nodules infiltrating at least the muscularis propria of the rectum, who received one of the following therapies: norethisterone acetate, triptorelin and tibolone, norethisterone acetate and letrozole, desogestrel, sequential oral contraceptive pill. The volume of the nodules was determined by virtual organ computer-aided analysis (VOCAL, GE Healthcare, USA) at baseline and after 6 and 12 months of treatment. Results: Eighty-three women (90.2 %) completed the 12-month treatment. When compared with baseline values, the volume of the nodules decreased at 6-month (p <0.001) and 12-month treatment (p <0.001). After 12-month treatment, the volume of the nodules decreased in all study groups. The volume of the nodules decreased during therapy in 68 women (73.9 %) and increased in 11 women (12.0 %). Conclusion: 12-month administration of hormonal therapies reduces the volume of rectovaginal endometriotic nodules infiltrating the rectum in the majority of cases.

KW - Desogestrel

KW - Letrozole

KW - Medical therapy

KW - Norethisterone acetate

KW - Rectal endometriosis

KW - Rectovaginal endometriosis

KW - Virtual organ computer-aided analysis

UR - http://www.scopus.com/inward/record.url?scp=84878359292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878359292&partnerID=8YFLogxK

U2 - 10.1007/s00404-012-2581-2

DO - 10.1007/s00404-012-2581-2

M3 - Article

VL - 287

SP - 447

EP - 453

JO - Archives of Gynecology

JF - Archives of Gynecology

SN - 0170-9925

IS - 3

ER -